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The generation of engineered tissues and organs has entered
into the clinical practice in response to the chronic lack of
organ donors. In particular, for the skeletal and cardiac muscles
the translational potential of tissue engineering approaches has
clearly been shown, even though the construction of these tissues
lags behind others given the hierarchical, highly organized archi-
tecture of striated muscles. Failure of the cardiac tissue leads to
cardiovascular diseases, which are the leading cause of death in
the developed world (Di Felice et al., 2014). On the other hand,
there are many clinical cases where the loss of skeletal muscle due
to a traumatic injury, an aggressive tumor, or prolonged den-
ervation may be cured by the regeneration of the muscle tissue
(Perniconi and Coletti, 2014).
In this volume, we have included articles from renowned
researchers in the fields of skeletal and cardiac muscle engineer-
ing who have contributed with methods, original research, and
review articles covering various aspects of native and synthetic
biomaterials or three-dimensional (3D) structures able to induce
stem cell differentiation and which may be used in pre-clinical
and clinical studies.
Of the two bio-artificial systems described, one is a silicon
chamber system for the generation of skeletal muscle constructs
described by Snyman et al. (2013). This inexpensive and read-
ily adaptable system (distance between pins, cell number, and
matrix-cell volume can be readily changed) may be used with
different hydrogels and applied to any existing culture cham-
bers. The other is a PEG-fibrinogen (PF)-based hydrogel scaffold
used to rejuvenate aged adult skeletal muscle-derived pericytes
(MP) from pig skeletal muscle. In this 3D environment peri-
cytes were able to recover their differentiation potential toward
myogenic differentiation and vessel formation. Fuoco and col-
leagues demonstrated that the 3D PF environment was beneficial
for swine-derived MP by mimicking the stiffness and mechani-
cal properties of young muscle extracellular matrix (ECM), thus,
“rejuvinating” aged MP may be an alternative to the use of myo-
genic progenitors; indeed, swine derived MP represent a valid
alternative to build human size comparable artificial muscle units
from the swine muscle (Fuoco et al., 2014).
The method of choice to seed stem cells in 3D cultures is
important, in order to form a densely packaged proto-tissue,
independently from the scaffold used. This step is fundamental
for the cells of the proto-tissue to complete their maturation pro-
cess and interconnect with the native tissue upon in vivo implan-
tation. Pagliari et al. (2014a) showed a method for sequential cell
seeding, where first gelatin scaffolds were colonized with human
mesenchymal stem cells in a static condition to favor endothe-
lialization; then the scaffolds were loaded with pre-committed
cardiac progenitors and cultured in perfusion bioreactor in car-
diogenic conditions. The authors obtained a well-packed cardiac
proto-tissue, rich in vessels, but without functional contractile or
vascular structures. They concluded that even the more complex
3D dynamic culture system needs to be improved with stretching
or electric stimulation to obtain mature, functional cardiac tissue.
A valid alternative to biosynthetic scaffolds are de-cellularized
organs, for example the muscle acellular scaffold (MAS) from
skeletal muscle. Perniconi et al. (2014) demonstrated that MAS
may be used to induce the differentiation of cultured myoblasts
and this is an excellent support for 3D myogenic cultures also
in vivo in orthotopical engraftments. MAS is histocompatible,
porous, degradable and non-toxic. This structure is stable in
anatomical sites other than the skeletal musculature, but does not
provide enough signals to trigger myogenesis by the colonizing
cells. The possibility to use MAS for the reconstruction of tis-
sue different from the skeletal muscle should be investigated. For
example, considering similarities between the skeletal and the car-
diac tissue, MAS might be used as an autologous native scaffold
for cardiac tissue transplantation.
The same authors also contributed a review article on the use-
fulness of the MAS as a scaffolding platform able to re-create the
natural structure of the muscle. MAS is naturally embedded with
active native molecules which remain active after the decellular-
ization process and help the implanted proto-tissue to integrate
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in the host organ. Tissue-derived ECMhelps in structuring niches
rich in adhesive and signaling molecules supporting stem cells
self-renewal and differentiation (Teodori et al., 2014).
When the muscle lesion is so extensive that the function of
the muscle is impaired, the definition of volumetric muscle losses
(VMLs) applies. In this case the muscle should be replaced by
devices able to re-establish the function of the musculature and
which preserve force transmission and continuity of the architec-
ture within the host tissues. Hence, Cittadella Vigodarzere and
Mantero (2014) described the architecture of the native skele-
tal tissue, identifying all the single elements which should be
taken into consideration in a skeletal muscle tissue engineer-
ing construct. They focused the attention on the vasculature
structures of constructs and, since decellularized ECM promotes
vascularization of the implanted construct, they concluded that
decellularized scaffolds are ready for a clinical application on
human.
A clinical example of the latter is described in an inter-
esting review discussing the importance of angiogenesis and
the pro-angiogenic and pro-myogenic effects of the vascular
endothelial growth factor (VEGF)/VEGF receptor pathway as
a therapeutic strategy to cure muscle weakness and cardiomy-
opathy in Duchenne muscular dystrophy (DMD) patients
(Shimizu-Motohashi and Asakura, 2014).
Apart from the structures of ECM and vasculature, also
growth factors, cytokines, pleiotropic signaling pathways, and
cell-specific regulators play an important role in the differentia-
tion and self-renewal of cardiac as well as skeletal muscle stem
cells. Pagliari et al. (2014b) described the most important signal-
ing pathways which influence the in vivo differentiation of cardiac
progenitor cells. Many of these pathways and factors have differ-
ent and distant effects on the differentiation process (JAK/STAT,
Hippo pathway, Wnt and Notch signaling, etc.).
This book provides a comprehensive up-to-date review on car-
diac and skeletal muscle tissue engineering and highlights the
several elements which have to be taken into consideration when
engineering a functional proto-tissue.
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